<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0213264</journal-id>
<journal-id journal-id-type="pubmed-jr-id">1117</journal-id>
<journal-id journal-id-type="nlm-ta">Biol Psychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">Biol. Psychiatry</journal-id>
<journal-title-group>
<journal-title>Biological psychiatry</journal-title>
</journal-title-group>
<issn pub-type="ppub">0006-3223</issn>
<issn pub-type="epub">1873-2402</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29576190</article-id>
<article-id pub-id-type="pmc">6984980</article-id>
<article-id pub-id-type="doi">10.1016/j.biopsych.2018.01.024</article-id>
<article-id pub-id-type="manuscript">NIHMS1066838</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Conference Report: ‘Psychiatric Genomics Consortium meeting: Pathways to Drugs’ London, March 2017</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Gaspar</surname>
<given-names>Héléna A.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Collier</surname>
<given-names>David A.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Geschwind</surname>
<given-names>Daniel H.</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lewis</surname>
<given-names>Cathryn M.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Qingqin</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Roth</surname>
<given-names>Bryan</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
<xref ref-type="aff" rid="A7">7</xref>
<xref ref-type="aff" rid="A8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sullivan</surname>
<given-names>Patrick</given-names>
</name>
<xref ref-type="aff" rid="A9">9</xref>
<xref ref-type="aff" rid="A10">10</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Breen</surname>
<given-names>Gerome</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>MRC Social, Genetic &amp; Developmental Psychiatry Centre, Institute of Psychiatry, Psychology &amp; Neuroscience, King’s College London, UK</aff>
<aff id="A2"><label>2</label>UK National Institute for Health Research (NIHR) Biomedical Research Centre for Mental Health, South London and Maudsley Hospital, London, UK</aff>
<aff id="A3"><label>3</label>Discovery Neuroscience Research, Eli Lilly and Company Ltd, Windlesham, Surrey, UK.</aff>
<aff id="A4"><label>4</label>Program in neurogenetics, department of Neurology and Center for Autism Research and Treatment, Department of Psychiatry, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, 760 Westwood Plaza Los Angeles, CA 90024, USA</aff>
<aff id="A5"><label>5</label>Neuroscience Therapeutic Area, Janssen Research &amp; Development, LLC, Titusville, New Jersey, USA.</aff>
<aff id="A6"><label>6</label>Department of Pharmacology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.</aff>
<aff id="A7"><label>7</label>National Institute of Mental Health Psychoactive Drug Screening Program (NIMH PDSP), School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.</aff>
<aff id="A8"><label>8</label>Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.</aff>
<aff id="A9"><label>9</label>Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.</aff>
<aff id="A10"><label>10</label>Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.</aff>
<author-notes>
<corresp id="CR1"><label>*</label><bold>Corresponding author:</bold> Gerome Breen, <email>gerome.breen@gmail.com</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>10</day>
<month>1</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>08</day>
<month>2</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<day>15</day>
<month>9</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>28</day>
<month>1</month>
<year>2020</year>
</pub-date>
<volume>84</volume>
<issue>6</issue>
<fpage>e49</fpage>
<lpage>e50</lpage>
<!--elocation-id from pubmed: 10.1016/j.biopsych.2018.01.024-->
<kwd-group>
<kwd>psychiatry</kwd>
<kwd>genomics</kwd>
<kwd>pathways</kwd>
<kwd>drug discovery</kwd>
<kwd>chemoinformatics</kwd>
<kwd>systems biology</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>